Thomas A. Rasmussen

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Thomas A. Rasmussen, Martin Tolstrup, Christel R. Brinkmann et al. · The Lancet HIV · 2014 · 641 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

Ole S. Søgaard, Mette E. Graversen, Steffen Leth et al. · PLoS Pathogens · 2015 · 523 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Comparison of HDAC inhibitors in clinical development

Thomas A. Rasmussen, Ole S. Søgaard, Christel R. Brinkmann et al. · Human Vaccines & Immunotherapeutics · 2013 · 190 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

Steffen Leth, Mariane Høgsbjerg Schleimann, Sara Konstantin Nissen et al. · The Lancet HIV · 2016 · 178 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection

Line K. Vibholm, Mariane Høgsbjerg Schleimann, Jesper Falkesgaard Højen et al. · Clinical Infectious Diseases · 2017 · 146 citations · Full text

Life Sciences, Immunology, Pharmacology +17